The basic science of Meniere's disease and endolymphatic hydrops

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 13, Issue 5, 2005, Pages 301-307

  Semaan, Maroun T ^a   Alagramam, Kumar N ^a   Megerian, Cliff A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Animal models; Apoptosis; Endolymphatic fluid homeostasis; Endolymphatic hydrops; Meniere's disease

Indexed keywords

ANIMAL TESTING REPLACEMENT; APOPTOSIS; AUTOIMMUNITY; CLINICAL FEATURE; DISEASE MODEL; ENDOLYMPH; EPISODIC VERTIGO; EXCITOTOXICITY; GENE EXPRESSION; GENETIC RISK; GUINEA PIG; HEARING LOSS; HOMEOSTASIS; MENIERE DISEASE; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPIRAL GANGLION; SYMPTOM; TINNITUS; VESTIBULOCOCHLEAR NERVE DISEASE;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOLYMPHATIC HYDROPS; HUMANS; MENIERE'S DISEASE; MICE;

EID: 25144465547     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000186335.44206.1c     Document Type: Review

References (48)

1. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005; 26:74-81. This paper outlines an innovative approach to the understanding of the chronology of development of endolymphatic hydrops and reviews archival temporal bone specimens with relevance to the topic.
2. Megenan CA. Cochlear nerve degeneration in endolymphatic hydrops: implications to the etiology of hearing loss in Meniere'e disease. Laryngoscope (Fall 2005).
3. Morrison AW, Johnson KJ. Genetics (molecular biology) and Meniere's disease. Otolaryngol Clin North Am 2002; 35:497-516.
4. Arweiler DJ, Jahnke K, Grosse-Wilde H. Meniere disease as an autosome dominant hereditary disease [in German]. Laryngorhinootologie 1995; 74:512-515.
5. Morrison AW, Mowbray JF, Williamson R, et al. On genetic and environmental factors in Meniere's disease. Am J Otol 1994; 15:35-39.
6. Xenellis J, Morrison AW, McClowskey D, et al. HLA antigens in the pathogenesis of Meniere's disease. J Laryngol Otol 1986; 100:21-24.
7. Passali D, Damiani V, Mora R, et al. PO antigen detection in sudden hearing loss and Meniere's disease: a new diagnostic marker? Acta Otolaryngol 2004; 124:1145-1148.
8. Tomiyama S. Development of endolymphatic hydrops following immune response in the endolymphatic sac of the guinea pig. Acta Otolaryngol 1992; 112:470-478.
9. Matsuoka H, Kwon SS, Yazawa Y, et al. Induction of endolymphatic hydrops by directly infused monoclonal antibody against type II collagen CB11 peptide. Ann Otol Rhinol Laryngol 2002; 111:587-592.
10. Salt AN, Ma Y. Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 2001; 154:88-97.
11. Beitz E, Zenner HP, Schultz JE. Aquaporin-mediated fluid regulation in the inner ear. Cell Mol Neurobiol 2003; 23:315-329.
12. Takeda T, Sawada S, Takeda S, et al. The effects of V2 antagonist (OPC-31260) on endolymphatic hydrops. Hear Res 2003; 182:9-18.
13. Salt AN, Rask-Andersen H. Responses of the endolymphatic sac to perilymphatic injections and withdrawals: evidence for the presence of a one-way valve. Hear Res 2004; 191:90-100.
14. Salt AN. Acute endolymphatic hydrops generated by exposure of the ear to nontraumatic low-frequency tones. J Assoc Res Otolaryngol 2004; 5:203-214.
15. Heller S. Application of physiological genomics to the study of hearing disorders. J Physiol 2002; 543:3-12.
16. Wangemann P. K+ cycling and the endocochlear potential. Hear Res 2002; 165:1-9.
17. Xia AP, Kikuchi T, Minowa O, et al. Late-onset hearing loss in a mouse model of DFN3 non-syndromic deafness: morphologic and immunohistochemical analyses. Hear Res 2002; 166:150-158.
18. Everett LA, Belyantseva IA, Noben-Trauth K, et al. Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 2001; 10:153-161.
19. Wangemann P, Itza EM, Albrecht B, et al. Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2004; 2:30.
20. Usami S, Abe S, Weston MD, et al. Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet 1999; 104:188-192.
21. Cheung EC, Melanson-Drapeau L, Cregan SP, et al. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J Neurosci 2005; 25:1324-1334.
22. Watanabe K, Inai S, Hess A, et al. Acoustic stimulation promotes the expression of inducible nitric oxide synthase in the vestibule of guinea pigs. Acta Otolaryngol Suppl 2004; 553:54-57.
23. Watanabe K, Tomiyama S, Jinnouchi K, et al. Expression of inducible nitric oxide synthase in the cochlea following immune response in the endolymphatic sac of guinea pigs. ORL J Otorhinolaryngol Relat Spec 2001; 63:155-159.
24. Michel O, Hess A, Su J, et al. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the hydropic cochlea of guinea pigs. Hear Res 2000; 143:23-28.
25. Urushitani M, Nakamizo T, Inoue R, et al. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J Neurosci Res 2001; 63:377-387.
26. Bras M, Queenan B, Susin SA. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 2005; 70:231-239. This paper details the mitochondrial pathway of apoptosis.
27. Mander P, Brown GC. Nitric oxide, hypoxia and brain inflammation. Biochem Soc Trans 2004; 32:1068-1069.
28. Furness DN, Lawton DM. Comparative distribution of glutamate transporters and receptors in relation to afferent innervation density in the mammalian cochlea. J Neurosci 2003; 23:11296-11304.
29. Pujol R, Puel JL. Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings. Ann N Y Acad Sci 1999; 884:249-254.
30. Furness DN, Hulme JA, Lawton DM, et al. Distribution of the glutamate/aspartate transporter GLAST in relation to the afferent synapses of outer hair cells in the guinea pig cochlea. J Assoc Res Otolaryngol 2002; 3:234-247.
31. Hakuba N, Koga K, Gyo K, et al. Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST. J Neurosci 2000; 20:8750-8753.
32. Matsuda K, Ueda Y, Doi T, et al. Increase in glutamate-aspartate transporter (GLAST) mRNA during kanamycin-induced cochlear insult in rats. Hear Res 1999; 133:10-16.
33. Watanabe K, Tomiyama S, Jinnouchi K, et al. Apoptosis in the hydropic cochlea of guinea pigs following immune reaction of the endolymphatic sac: immunohistochemical analysis. Eur Arch Otorhinolaryngol 2001; 258:296-299.
34. Van De Water TR, Lallemend F, Eshraghi AA, et al. Caspases, the enemy within, and their role in oxidative stress-induced apoptosis of inner ear sensory cells. Otol Neurotol 2004; 25:627-632. This article reviews the role of apoptosis in inner ear diseases.
35. Watanabe K, Inai S, Jinnouchi K, et al. Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs. Auris Nasus Larynx 2003; 30:219-225.
36. Labbé D, Teranishi MA, Hess A, et al. Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea. Hear Res 2005; 202: 1-27. This study is pertinent as it demonstrates the expression of markers of apoptosis and oxidative stress in endolymphatic hydrops.
37. Cunningham LL, Matsui JI, Warchol ME, et al. Overexpression of Bcl-2 prevents neomycin-induced hair cell death and caspase-9 activation in the adult mouse utricle in vitro. J Neurobiol 2004; 60:89-100.
38. Varela-Nieto I, Morales-Garcia JA, Vigil P, et al. Trophic effects of insulin-like growth factor-I (IGF-I) in the inner ear. Hear Res 2004; 196:19-25.
39. Zhang M, Liu W, Ding D, et al. Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Neuroscience 2003; 120:191-205.
40. Shimizu A, Takumida M, Anniko M, et al. Calpain and caspase inhibitors protect vestibular sensory cells from gentamicin ototoxicity. Acta Otolaryngol 2003; 123:459-465.
41. Ylikoski J, Xing-Qun L, Virkkala J, et al. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibuiar hair cell death. Hear Res 2002; 163:71-81.
42. Rauch SD, Zhou G, Kujawa SG, et al. Vestibular evoked myogenic potentials show altered tuning in patients with Meniere's disease. Otol Neurotol 2004; 25:333-338.
43. Rauch SD, Silveira MB, Zhou G, et al. Vestibular evoked myogenic potentials versus vestibular test battery in patients with Meniere's disease. Otol Neurotol 2004; 25:981-986. This paper outlines the importance of VEMP in the diagnosis of endolymphatic hydrops.
44. Magliulo G, Cianfrone G, Gagliardi M, et al. Vestibular evoked myogenic potentials and distortion-product otoacoustic emissions combined with glycerol testing in endolymphatic hydrops: their value in early diagnosis. Ann Otol Rhinol Laryngol 2004; 113:1000-1005.
45. Lohuis PJ, Klis SF, Klop WM, et al. Signs of endolymphatic hydrops after perilymphatic perfusion of the guinea pig cochlea with cholera toxin: a pharmacological model of acute endolymphatic hydrops. Hear Res 1999; 137:103-113.
46. Dunnebier EA, Segenhout JM, Dijk F, et al. Sensory cell damage in two-phase endolymphatic hydrops: a morphologic evaluation of a new experimental model by low-voltage scanning techniques. Otol Neurotol 2001; 22:655-661.
47. Hulander M, Kiernan AE, Blomqvist SR, et al. Lack of pendrin expression leads to deafness and expansion of the endolymphatic compartment in inner ears of Foxi1 null mutant mice. Development 2003; 130:2013-2025.
48. Lorenz-Depiereux B, Guido VE, Johnson KR, et al. New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice. Mamm Genome 2004; 15:151-161.